D-HPAEC, Pulmonary Artery Endothelial Cells, Diabetes T1
Cryopreserved ampule of Renal Cortical Epithelial Cells (HRCE) containing ≥500,000 cells
Cryopreserved ampule of Mouse Brain CD1 Hippocampus Neurons containing ≥ 1,000,000 cells
Culture system containing hMSC Chondrogenic Basal Medium (PT-3925) and hMSC Chondrogenic SingleQuots® Kit Supplement (PT-4121) required for hMSC chondrogenic differentiation
Cryopreserved ampule of Normal Human Pulmonary Artery Endothelial Cells (HPAEC) containing ≥ 500,000 cells
Cryopreserved human leukapheresis product (≥5.0 billion cells)
Cryopreserved human leukapheresis product (≥9.5 billion cells)
For rapid determination of Nucleofection conditions for primary cell types lacking an Optimized Protocol for the 4D-Nucleofector® Y Unit.
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
Natural Killer (NK) Cell Culture, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
References - X-Vivo™Overview of relevant references
-
Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic ResearchLonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
-
Cryopreserved Neural Cells and MediaLonza's Cryopreserved Neurons Offer Comparable Results to Fresh Cells
-
Instructions - Neural Progenitor Cell System, NHNPInstructions for Proper Use